Sponsor pipeline

Treeline Biosciences, Inc. clinical trial pipeline

Get alerts when Treeline Biosciences, Inc.'s trials change

4 active trials 3 recruiting 5 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
4

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1
NCT07713732 TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors Small Cell Lung Cancer ( SCLC ) Recruiting 2026-10-01
NCT07082803 TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas Lymphoma Recruiting 2026-09-04
NCT07204340 TLN-372 in Advanced KRAS Mutant Solid Tumors KRAS Mutant Solid Tumors Recruiting 2026-07-28
NCT06733441 A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma Lymphoma Active, Not Recruiting 2026-08-18

Disease areas by active trials

Lung Cancer (1) · Mesothelioma (1) · Non-Hodgkin Lymphoma (1) · Sarcoma (1) · Small Cell Lung Cancer (1)

Get alerts when Treeline Biosciences, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free